Thomas Watkins - Sep 29, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Sep 29, 2023
Transactions value $
$1,106,550
Form type
4
Date filed
10/2/2023, 07:32 PM
Previous filing
Jul 28, 2023
Next filing
Oct 6, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $492K +40K +137.34% $12.29* 69.1K Sep 29, 2023 Direct
transaction HZNP Ordinary Shares Options Exercise $319K +20K +28.93% $15.96* 89.1K Sep 29, 2023 Direct
transaction HZNP Ordinary Shares Options Exercise $296K +21.3K +23.93% $13.87* 110K Sep 29, 2023 Direct
holding HZNP Ordinary Shares 10K Sep 29, 2023 By Family Limited Partnership
holding HZNP Ordinary Shares 56K Sep 29, 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (right to buy) Options Exercise $0 -40K -100% $0.00* 0 Sep 29, 2023 Ordinary shares 40K $12.29 Direct F1
transaction HZNP Stock Option (right to buy) Options Exercise $0 -20K -100% $0.00* 0 Sep 29, 2023 Ordinary shares 20K $15.96 Direct F1
transaction HZNP Stock Option (right to buy) Options Exercise $0 -21.3K -66.3% $0.00 10.8K Sep 29, 2023 Ordinary shares 21.3K $13.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested.